Spacers in radiotherapy treatment of prostate cancer: Is reduction of toxicity cost-effective?
Open Access
- 1 February 2015
- journal article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 114 (2) , 276-281
Abstract
No abstract availableKeywords
This publication has 24 references indexed in Scilit:
- A Multi-institutional Clinical Trial of Rectal Dose Reduction via Injected Polyethylene-Glycol Hydrogel During Intensity Modulated Radiation Therapy for Prostate Cancer: Analysis of Dosimetric OutcomesInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2013
- Cost-Effectiveness Analysis of Stereotactic Body Radiation Therapy Versus Intensity-Modulated Radiation Therapy: An Emerging Initial Radiation Treatment Option for Organ-Confined Prostate CancerJournal of Oncology Practice, 2012
- Is It Time to Tailor the Prediction of Radio-Induced Toxicity in Prostate Cancer Patients? Building the First Set of Nomograms for Late Rectal SyndromeInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2012
- Application of a spacer gel to optimize three-dimensional conformal and intensity modulated radiotherapy for prostate cancerRadiotherapy and Oncology, 2011
- Effects of Prostate-Rectum Separation on Rectal Dose From External Beam RadiotherapyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2010
- Dose–volume effects for normal tissues in external radiotherapy: PelvisRadiotherapy and Oncology, 2009
- Role of Intensity-Modulated Radiotherapy in Reducing Toxicity in Dose Escalation for Localized Prostate CancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2009
- Transperineal Injection of Hyaluronic Acid in Anterior Perirectal Fat to Decrease Rectal Toxicity From Radiation Delivered With Intensity Modulated Brachytherapy or EBRT for Prostate Cancer PatientsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2007
- Time Course and Predictors of Symptoms After Primary Prostate Cancer TherapyJournal of Clinical Oncology, 2003
- Costs, effects and C/E‐ratios alongside a clinical trialHealth Economics, 1994